Lichen planopilaris induced by infliximab: A case report

Infliximab is a tumor necrosis factor-alpha inhibitor used to treat a range of inflammatory diseases. Most reports of cutaneous eruptions from tumor necrosis factor-alpha inhibitors have described the paradoxical development of psoriasis or psoriasiform drug reaction. In our report, we present a 31-...

Descripción completa

Detalles Bibliográficos
Autores principales: McPhie, Meghan L, Wang, Ami, Molin, Sonja, Herzinger, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
JCMS Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987482/
https://www.ncbi.nlm.nih.gov/pubmed/32064112
http://dx.doi.org/10.1177/2050313X20901967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987482/
https://www.ncbi.nlm.nih.gov/pubmed/32064112
http://dx.doi.org/10.1177/2050313X20901967

Ejemplares similares